Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 34 studies | 37% ± 17% | |
fibroblast | 33 studies | 35% ± 15% | |
ciliated cell | 11 studies | 28% ± 8% | |
connective tissue cell | 11 studies | 29% ± 10% | |
myeloid cell | 8 studies | 36% ± 11% | |
pericyte | 6 studies | 23% ± 7% | |
myofibroblast cell | 6 studies | 27% ± 10% | |
astrocyte | 6 studies | 30% ± 10% | |
endothelial cell | 4 studies | 23% ± 6% | |
monocyte | 4 studies | 47% ± 16% | |
adventitial cell | 4 studies | 45% ± 20% | |
podocyte | 3 studies | 57% ± 16% | |
basal cell | 3 studies | 28% ± 9% | |
mononuclear phagocyte | 3 studies | 35% ± 5% | |
tissue-resident macrophage | 3 studies | 46% ± 8% | |
conventional dendritic cell | 3 studies | 23% ± 10% | |
microglial cell | 3 studies | 29% ± 12% | |
smooth muscle cell | 3 studies | 22% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
uterus | 4 studies | 21% ± 4% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 12022.78 | 180 / 180 | 98% | 341.54 | 422 / 430 |
skin | 96% | 4147.93 | 1735 / 1809 | 99% | 417.47 | 466 / 472 |
lung | 100% | 7614.83 | 577 / 578 | 92% | 234.92 | 1057 / 1155 |
brain | 91% | 4120.72 | 2406 / 2642 | 99% | 425.32 | 701 / 705 |
pancreas | 100% | 7998.89 | 328 / 328 | 89% | 142.07 | 159 / 178 |
bladder | 100% | 6732.90 | 21 / 21 | 83% | 180.51 | 417 / 504 |
uterus | 100% | 8814.21 | 170 / 170 | 81% | 176.80 | 371 / 459 |
stomach | 99% | 5365.76 | 355 / 359 | 81% | 138.85 | 233 / 286 |
esophagus | 97% | 5840.10 | 1403 / 1445 | 77% | 173.65 | 140 / 183 |
breast | 100% | 9737.99 | 458 / 459 | 70% | 81.69 | 781 / 1118 |
intestine | 97% | 5557.35 | 939 / 966 | 72% | 114.57 | 381 / 527 |
kidney | 98% | 12361.00 | 87 / 89 | 66% | 151.03 | 591 / 901 |
prostate | 92% | 3902.33 | 226 / 245 | 54% | 52.89 | 270 / 502 |
thymus | 88% | 3601.98 | 577 / 653 | 48% | 700.14 | 293 / 605 |
adrenal gland | 100% | 14062.24 | 257 / 258 | 36% | 67.67 | 82 / 230 |
adipose | 100% | 19497.98 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 348.28 | 80 / 80 |
ureter | 0% | 0 | 0 / 0 | 100% | 50.51 | 1 / 1 |
blood vessel | 96% | 9119.18 | 1288 / 1335 | 0% | 0 | 0 / 0 |
heart | 93% | 5132.01 | 802 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 86% | 212.52 | 25 / 29 |
tonsil | 0% | 0 | 0 / 0 | 82% | 119.58 | 37 / 45 |
spleen | 70% | 3906.90 | 169 / 241 | 0% | 0 | 0 / 0 |
liver | 27% | 881.35 | 60 / 226 | 17% | 26.42 | 70 / 406 |
muscle | 24% | 620.14 | 190 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 13% | 567.31 | 119 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0015914 | Biological process | phospholipid transport |
GO_0046836 | Biological process | glycolipid transport |
GO_0015918 | Biological process | sterol transport |
GO_0120009 | Biological process | intermembrane lipid transfer |
GO_0035627 | Biological process | ceramide transport |
GO_0034375 | Biological process | high-density lipoprotein particle remodeling |
GO_0006869 | Biological process | lipid transport |
GO_0010189 | Biological process | vitamin E biosynthetic process |
GO_0030317 | Biological process | flagellated sperm motility |
GO_0010875 | Biological process | positive regulation of cholesterol efflux |
GO_0006629 | Biological process | lipid metabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005576 | Cellular component | extracellular region |
GO_0034364 | Cellular component | high-density lipoprotein particle |
GO_0005634 | Cellular component | nucleus |
GO_0120017 | Molecular function | ceramide transfer activity |
GO_0140337 | Molecular function | diacylglyceride transfer activity |
GO_0097001 | Molecular function | ceramide binding |
GO_1901611 | Molecular function | phosphatidylglycerol binding |
GO_0140339 | Molecular function | phosphatidylglycerol transfer activity |
GO_0120020 | Molecular function | cholesterol transfer activity |
GO_0008526 | Molecular function | phosphatidylinositol transfer activity |
GO_0140338 | Molecular function | sphingomyelin transfer activity |
GO_0140340 | Molecular function | cerebroside transfer activity |
GO_0120014 | Molecular function | phospholipid transfer activity |
GO_0031210 | Molecular function | phosphatidylcholine binding |
GO_0030169 | Molecular function | low-density lipoprotein particle binding |
GO_0120019 | Molecular function | phosphatidylcholine transfer activity |
GO_0070300 | Molecular function | phosphatidic acid binding |
GO_1990050 | Molecular function | phosphatidic acid transfer activity |
GO_0008429 | Molecular function | phosphatidylethanolamine binding |
GO_0008035 | Molecular function | high-density lipoprotein particle binding |
GO_0034189 | Molecular function | very-low-density lipoprotein particle binding |
GO_1904121 | Molecular function | phosphatidylethanolamine transfer activity |
GO_0019992 | Molecular function | diacylglycerol binding |
Gene name | PLTP |
Protein name | Phospholipid transfer protein, isoform CRA_c (cDNA FLJ39690 fis, clone SMINT2010639, highly similar to PHOSPHOLIPID TRANSFER PROTEIN) Phospholipid transfer protein (Lipid transfer protein II) |
Synonyms | hCG_37180 |
Description | FUNCTION: Mediates the transfer of phospholipids and free cholesterol from triglyceride-rich lipoproteins (low density lipoproteins or LDL and very low density lipoproteins or VLDL) into high-density lipoproteins (HDL) as well as the exchange of phospholipids between triglyceride-rich lipoproteins themselves . Facilitates the transfer of a spectrum of different lipid molecules, including diacylglycerol, phosphatidic acid, sphingomyelin, phosphatidylcholine, phosphatidylinositol, phosphatidylglycerol, cerebroside and phosphatidyl ethanolamine . Plays an important role in HDL remodeling which involves modulating the size and composition of HDL . Also plays a key role in the uptake of cholesterol from peripheral cells and tissues that is subsequently transported to the liver for degradation and excretion . Two distinct forms of PLTP exist in plasma: an active form that can transfer phosphatidylcholine from phospholipid vesicles to HDL, and an inactive form that lacks this capability . . |
Accessions | ENST00000420868.2 [P55058-3] ENST00000372420.5 [P55058-4] ENST00000477313.5 [P55058-1] ENST00000372431.8 [P55058-1] B3KUE5 P55058 ENST00000354050.8 [P55058-2] |